Back
Nemaura Medical, Inc. 10K Form
Sell
17
NMRD
Nemaura Medical, Inc.
Last Price:
$0.0001
Seasonality Move:
2.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-14 | 10Q | NMRD/Nemaura Medical, Inc. Quarterly |
| 2020-06-29 | 10K | NMRD/Nemaura Medical, Inc. Annual |
| 2020-02-10 | 10Q | NMRD/Nemaura Medical, Inc. Quarterly |
| 2019-11-08 | 10Q | NMRD/Nemaura Medical, Inc. Quarterly |
| 2019-08-09 | 10Q | NMRD/Nemaura Medical, Inc. Quarterly |
| 2019-06-14 | 10K | NMRD/Nemaura Medical, Inc. Annual |
Receive NMRD News And Ratings
See the #1 stock for the next 7 days that we like better than NMRD
NMRD Financial Statistics
Sales & Book Value
| Annual Sales: | $77K |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | $-1.9M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Nemaura Medical, Inc. Earnings Forecast
Key Nemaura Medical, Inc. Financial Ratios
-
The Gross Profit Margin over the past 11 years for NMRD is -2,494.29%.
-
The Selling, General & Administrative Expenses for NMRD have been equal to 7,272.99% of Gross Profit Margin.
-
The Research & Development expenses have been 1,998.18% of Revenue.
-
The Net Earning history of NMRD is -18,368.44% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 5 years.
Nemaura Medical, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | NMRD |
| CUSIP: | 640442 |
| Website: | nemauramedical.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NMRD Technical Analysis vs Fundamental Analysis
Sell
17
Nemaura Medical, Inc. (NMRD)
is a Sell
Is Nemaura Medical, Inc. a Buy or a Sell?
-
Nemaura Medical, Inc. stock is rated a SellThe current Nemaura Medical, Inc. [NMRD] share price is $0.0000. The Score for NMRD is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.